- Report
- June 2025
- 400 Pages
Global
From €4411EUR$4,949USD£3,826GBP
- Clinical Trials
- November 2025
- 326 Pages
Global
From €3075EUR$3,450USD£2,667GBP
- Report
- July 2025
- 75 Pages
Global
From €16040EUR$17,995USD£13,910GBP
- Report
- March 2025
- 74 Pages
Global
From €16040EUR$17,995USD£13,910GBP
- Report
- March 2025
- 200 Pages
Global
From €2219EUR$2,490USD£1,925GBP
- Report
- January 2026
- 194 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- January 2026
- 197 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- January 2026
- 184 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- January 2026
- 187 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- August 2025
- 180 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- January 2026
- 182 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 383 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 194 Pages
Global
From €4412EUR$4,950USD£3,826GBP
- Report
- January 2026
- 193 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- January 2026
- 182 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- January 2026
- 180 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- January 2026
- 195 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- August 2025
- 192 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- September 2025
- 250 Pages
Global
From €4002EUR$4,490USD£3,471GBP
- Report
- November 2025
- 200 Pages
Global
From €7086EUR$7,950USD£6,145GBP

Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery.
Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more